See also this year's filing and all EDGAR filings for this company.
PDF Report 0001274792_2017_MERRIMACK_PHARMACEUTICALS_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001274792')"} |
Graph
Absolute values for 0001274792, MERRIMACK PHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 57,435,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 7,582,000 |
| 2 | PropertyPlantAndEquipmentNet | 15,765,000 |
| 3 | remainder_Assets | 701,000 |
| 4 | LiabilitiesCurrent | 88,222,000 |
| 5 | LiabilitiesNoncurrent | 216,861,000 |
| 6 | remainder_Liabilities | 29,059,000 |
| 7 | CostOfGoodsAndServicesSold | 6,912,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 80,729,000 |
| 9 | ResearchAndDevelopmentExpense | 160,917,000 |
| 10 | remainder_Expenses | 49,501,000 |
| 11 | remainder_Revenues | 144,273,000 |
| 12 | remainder_NetIncome | 268,000 |
| 13 | remainder_ComprehensiveNetIncome | 1,778,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 81,483,000 |
| 1 | Liabilities | 334,142,000 |
| 2 | Expenses | 298,059,000 |
| 3 | Revenues | 144,273,000 |
| 4 | StockholdersEquity | -252,659,000 |
| 5 | NetIncome | -153,518,000 |
| 6 | ComprehensiveNetIncome | -152,629,000 |
| 7 | BaseVar | 430,001,500 |
| 8 | EconomicCapitalRatio | -2.83 |
Edgar->Model Mapping
Feature Distribution
